In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Mark S. Freedman, MSc, MD, FRCPC
Professor of Neurology
University of Ottawa
Financial Relationship Disclosure:
Consulting Fees: Bayer, Biogen, EMD Serono, Inc., Genzyme, GSK, Novartis, Roche Diagnostics, Sanofi, and Teva Pharmaceutical
- Ann Early has nothing to disclose.
- Barry A. Fiedel, PhD has nothing to disclose.
- Ashley Pluta has nothing to disclose.
- Lawrence Sherman, FACEHP, CHCP has nothing to disclose.